Wait a few moments, please...  Wait a few moments, please...
    
Metadata (Opens new window)Get table previously savedSave tableDownload Chart (JPEG, PNG or PDF format)Conventional signs (Opens new window)

Place of residence (NUTS II - 1999) (1) Vaccination coverage to individuals who complete 6 years of age (2017 - %) by Place of residence (NUTS II) and Type of administrated vaccine; Annual (3)
Data reference period (2)
2021
Type of administrated vaccine
Dif5: Vaccine against diphteria (5th inoculations)Tet5: Vaccine against tetanus (5th inoculations)Tcp5: Vaccine against whooping cough/pertussis (5th inoculations)Sar2: Vaccine agains measles (2nd inoculations)Par2: Vaccine against mumps (2nd inoculations)Rub2: Vaccine against rubella (2nd inoculations)VIP4: Injectable inactivated vaccine against polio (4th inoculations)VIP5: Injectable inactivated vaccine against polio (5th inoculations)
% % % % % % % %
PT: Portugal92,892,892,894,794,794,7x92,8
1: Continente92,592,592,594,594,594,5x92,5
2: Região Autónoma dos Açores97,697,697,697,497,497,4x97,6
3: Região Autónoma da Madeira96,496,496,497,097,097,0x96,4
Vaccination coverage to individuals who complete 6 years of age (2017 - %) by Place of residence (NUTS II) and Type of administrated vaccine; Annual - Directorate-General of Health
Note(s):
(1) From 2017 onwards, vaccine coverage will be made available by vaccine against a disease, not by monovalent or combined vaccine;
(2) These values are in accordance with the recommended scheme.
(3) Since 2016, BCG vaccine is recommended only for at-risk groups.

This data last updated:march 03, 2023